Clinical Research
Why Choose Actistatin®?
Actistatin® isn't just another joint supplement—it's a scientifically proven solution trusted by veterinarians and thousands of pet owners across Canada. With over 8 years of rigorous clinical studies, Actistatin® has consistently demonstrated unmatched results for joint health in dogs and horses.
Scientifically Validated Results
Clinical trials have shown that Actistatin® delivers remarkable improvements in joint mobility, reducing pain and enhancing quality of life. Notably, animals receiving Actistatin® exhibited over 60% absorption of active ingredients into their bloodstream—far exceeding standard glucosamine and chondroitin supplements.
Advanced Triple-Patented Formula
Our proprietary formula combines glucosamine, chondroitin, hyaluronic acid, antioxidants, and essential minerals. This unique blend boosts bioavailability, ensuring maximum delivery of active nutrients directly to joints and tissues.
Real Improvements, Backed by Research
In extensive studies:
- Horses and dogs showed significant reductions in joint pain and stiffness.
- Mobility and activity levels improved within as little as 10 days.
- Regular use resulted in prolonged periods between veterinary interventions and joint injections.
Clinical Studies You Can Trust
Actistatin’s clinical trials were conducted under strict scientific standards. Highlights include:
- Montgomery et al. (2011) Clinical Trial demonstrated significant pain reduction and enhanced mobility in horses using Actistatin®.
- A comprehensive Glucosamine & Chondroitin Meta-Analysis (1956–2006) reviewed decades of evidence confirming the effectiveness of glucosamine and chondroitin.
- Fenestra Research Laboratories (2009) confirmed superior absorption rates of glucosamine and chondroitin in canine subjects using Actistatin® products.
- Rodgers (2006) Equine Clinical Trial highlighted the ability of Actistatin® to significantly reduce the need for joint injections in competitive horses.